Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
David Topper Joined Inmagene as CFO 2023-09-05 20:00
I-Mab Announces Upcoming Participation at September Conferences 2023-09-05 20:00
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001 2023-09-05 14:00
Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement 2023-09-01 21:30
Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities 2023-09-01 20:08
CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023 2023-08-31 15:15
LOTTE BIOLOGICS Holds 'ESG Declaration Ceremony' 2023-08-31 09:00
GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community 2023-08-30 16:05
Asieris Obtained IND Approval from NMPA for APL-1401, a Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2023-08-30 14:19
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for OMTX705, a First-in-Class FAP-Targeting ADC 2023-08-30 11:00
Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF 2023-08-30 08:03
Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development 2023-08-30 08:00
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:02
Akeso Announced Completion of Patient Enrollment in Phase 3 Trial of Ivonescimab (PD-1/VEGF) versus Pembrolizumab in First-line PD-L1 Positive Advanced NSCLC 2023-08-29 20:00
ProfoundBio to Participate in the 21st Annual Morgan Stanley Conference 2023-08-28 20:00
Harbour BioMed Announces 2023 Interim Results 2023-08-28 17:08
Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors 2023-08-28 16:30
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan 2023-08-28 11:42
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy 2023-08-28 04:00
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial 2023-08-25 20:58
1 41 42 43 44 45 222